HBM Global Biotechnology Fund A cap USD/ LU1540961759 /
NAV24/06/2024 | Chg.+10.8400 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
466.8800USD | +2.38% | reinvestment | Equity | FundPartner Sol.(EU) ▶ |
Funds documents
Date | Document | Year | Language | Filesize |
---|---|---|---|---|
27/06/2024 | Public WebStation Live Factsheet | 2024 | English | - |
31/12/2023 | Account statment | 2023 | English | 4,345.03 KB |
30/06/2023 | Semi-annual report | 2023 | German | 850.93 KB |
23/02/2023 | PRIIP Key Information Document | 2023 | German | 111.55 KB |
01/02/2023 | Prospectus | 2023 | English | 848.35 KB |
01/01/2023 | PRIIP Key Information Document | 2023 | English | 87.29 KB |
30/06/2022 | Semi-annual report | 2022 | English | 770.62 KB |
18/02/2022 | Key Investor Information | 2022 | German | 82.33 KB |
01/03/2021 | Prospectus | 2021 | German | 703.67 KB |
31/12/2019 | Account statment | 2019 | German | 1,047.35 KB |